Bevacizumab in Combination With Chemotherapy in the Neo-adjuvant Setting for HER2 (-) Breast Cancer
Clinical trial NCT01985841 · TERMINATED
Trial details
- NCT number
- NCT01985841
- Sponsor
- Hellenic Oncology Research Group
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-01
- Primary completion
- 2015-04-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.